EditorialCreativeSportsCollectionsVideos
Prices
0Log in

Visual content for professionals.
800M+ images and videos.

Content Hub

  • Current Events
  • Pictures of the Year
  • Sports
  • Editorial
  • Creative
  • Collections
  • Videos

Offers

  • Prices & Packages
  • Promotions
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Content Research
  • Contract Photography
  • API & FTP Push
  • my-picturemaxx
  • Become a Partner

Company

  • About IMAGO
  • Careers
  • News

Help Center

  • FAQ
  • Contact Us
Legal NoticeTerms & ConditionsLicense InformationData PrivacyPrivacy Settings
© 2026 IMAGO
CEPICBAPLABVPA
  3. Coronavirus, Janssen Biologics in Leiden, Netherlands

Coronavirus, Janssen Biologics in Leiden, Netherlands

Mar 31, 2020

The following photos have been selected for you by the IMAGO picture desk on this topic. For more pictures please use the search function.

Images in this collection

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

Collections